IIQ 3.64% 53.0¢ inoviq ltd

Ann: BARD1 Signs Option Agreement for Type 3C Diabetes Test, page-32

  1. 16,181 Posts.
    lightbulb Created with Sketch. 3791
    It's a clear strategy. They are using the same with Ovarian, targeting those at higher genetic risk
 
watchlist Created with Sketch. Add IIQ (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.